Egyptian International Pharmaceutical Industries Company (EGX: PHAR)
Egypt
· Delayed Price · Currency is EGP
49.28
0.00 (0.00%)
At close: Oct 15, 2024
PHAR Revenue
Egyptian International Pharmaceutical Industries Company had revenue of 1.88B EGP in the quarter ending June 30, 2024, with 89.33% growth. This brings the company's revenue in the last twelve months to 6.34B, up 42.14% year-over-year. In the year 2023, Egyptian International Pharmaceutical Industries Company had annual revenue of 5.23B with 32.27% growth.
Revenue (ttm)
6.34B
Revenue Growth
+42.14%
P/S Ratio
1.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.23B | 1.28B | 32.27% |
Dec 31, 2022 | 3.96B | 546.35M | 16.03% |
Dec 31, 2021 | 3.41B | 523.18M | 18.13% |
Dec 31, 2020 | 2.89B | -525.41M | -15.40% |
Dec 31, 2019 | 3.41B | 595.47M | 21.15% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition